Nimotop

Designed to support cerebral arterial blood flow to manage neurological safety and alleviate local arterial spasm.

Dosage

Pack size

You will receive a quality generic equivalent of Nimotop, depending on stock.

Prescription and consultation requirements for Nimotop vary by destination and are determined by the fulfilment partner.

Nimotop details

Condition: Subarachnoid Haemorrhage-associated Neurological Deficits Reduction
Alternative names: nimodipine
Therapeutic class: Dihydropyridine Calcium Channel Blocker
Pharmacological class: Cerebral Vasodilator
Known off-label uses: migraine
Contraindications: concurrent use of strong CYP3A4 inhibitors
Minor side effects: headache; nausea; dizziness
Moderate side effects: hypotension; diarrhoea; flushing
Serious side effects: severe cardiovascular collapse, requires immediate medical attention
Dosage forms: Capsule
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Originator: Bayer
Onset Time: 1 hour
Duration: 4–6 hours
Storage instructions: Store below 25°C. Protect from light.
Drug interactions: Clarithromycin; Rifampin; Antihypertensives
Age restrictions: Approved for adults.

Patient summary

designed to support cerebral arterial blood flow to manage neurological safety and alleviate local arterial spasm.

Mechanism of action

Selectively blocks calcium channels in cerebral arterial walls, preventing arterial spasms and subsequent tissue ischaemia.

Pregnancy and breastfeeding

TGA Category C: Use if potential benefit outweighs risk. Breastfeeding: Consult a doctor.

Nimotop is the originator brand name, made by Bayer. We use it to identify the medicine and are not affiliated with Bayer.

The fulfilment partner confirms whether the exact brand or an equivalent containing Nimodipine is offered.
The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
Check the final product details at checkout before confirming an order.